Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2025-12-24 @ 7:55 PM
NCT ID: NCT01452204
Eligibility Criteria: Inclusion Criteria: 1. The patient must have a diagnosis of impingement of the rotator cuff grade II or grade III. For patients with grade III, they must present at least 90 ° of active elevation of the affected shoulder-free. Patients with extensive lesions of the rotator cuff will be deleted. 2. The patient must be aged between 30 and 50 years, of both sexes. 3. Patients should not use any anti-inflammatory, analgesic and / or chondroprotective by at least one week before the start of treatment. 4. The patient must not have been subjected to intra-articular injection of corticosteroids for at least 30 days before the start of treatment. 5. The patient can not be being subjected to physical therapy for at least 30 days before the start of treatment. 6. Patient must have at least 3 months of discomfort and / or symptoms of impingement syndrome. Exclusion Criteria: 1. Make use of systemic anti-inflammatory medications and / or topics during the study. 2. Patient presenting during pregnancy or postpartum. 3. A patient with cancer, even if you are treated. 4. Having been subjected to surgery on the shoulder to receive the study treatment 5. submit inflammatory joint diseases (such as rheumatoid arthritis, lupus, gout, etc.) except for the impingement of the rotator cuff. 6. Patients who do not submit high active-free up to 90 degrees (minimum) of the affected shoulder will be deleted. These cases are specific to patients with extensive lesions of the rotator cuff and have no function of this muscle group.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT01452204
Study Brief:
Protocol Section: NCT01452204